Your browser doesn't support javascript.
loading
Comparison of full-dose gemcitabine/cisplatin, dose-reduced gemcitabine/cisplatin, and gemcitabine/carboplatin in real-world patients with advanced urothelial carcinoma.
Sugimoto, Kazuma; Taguchi, Satoru; Kishitani, Kenjiro; Kawai, Taketo; Masuda, Kazuki; Nakamura, Yu; Kinjo, Manami; Tambo, Mitsuhiro; Miyakawa, Jimpei; Akiyama, Yoshiyuki; Yamada, Yuta; Sato, Yusuke; Yamada, Daisuke; Nakagawa, Tohru; Fukuhara, Hiroshi; Kume, Haruki.
Affiliation
  • Sugimoto K; Department of Urology, Kyorin University School of Medicine, 6-20-2 Shinkawa, Mitaka, Tokyo, 181-8611, Japan.
  • Taguchi S; Department of Urology, Kyorin University School of Medicine, 6-20-2 Shinkawa, Mitaka, Tokyo, 181-8611, Japan. satorutaguchi33@gmail.com.
  • Kishitani K; Department of Urology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan. satorutaguchi33@gmail.com.
  • Kawai T; Department of Urology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.
  • Masuda K; Department of Urology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.
  • Nakamura Y; Department of Urology, Teikyo University School of Medicine, 2-11-1 Kaga, Itabashi-ku, Tokyo, 173-8605, Japan.
  • Kinjo M; Department of Urology, Kyorin University School of Medicine, 6-20-2 Shinkawa, Mitaka, Tokyo, 181-8611, Japan.
  • Tambo M; Department of Urology, Kyorin University School of Medicine, 6-20-2 Shinkawa, Mitaka, Tokyo, 181-8611, Japan.
  • Miyakawa J; Department of Urology, Kyorin University School of Medicine, 6-20-2 Shinkawa, Mitaka, Tokyo, 181-8611, Japan.
  • Akiyama Y; Department of Urology, Kyorin University School of Medicine, 6-20-2 Shinkawa, Mitaka, Tokyo, 181-8611, Japan.
  • Yamada Y; Department of Urology, Kyorin University School of Medicine, 6-20-2 Shinkawa, Mitaka, Tokyo, 181-8611, Japan.
  • Sato Y; Department of Urology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.
  • Yamada D; Department of Urology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.
  • Nakagawa T; Department of Urology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.
  • Fukuhara H; Department of Urology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.
  • Kume H; Department of Urology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.
BMC Urol ; 22(1): 177, 2022 Nov 09.
Article in En | MEDLINE | ID: mdl-36352389
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Urinary Bladder Neoplasms / Carcinoma, Transitional Cell Type of study: Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: BMC Urol Journal subject: UROLOGIA Year: 2022 Document type: Article Affiliation country: Japón Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Urinary Bladder Neoplasms / Carcinoma, Transitional Cell Type of study: Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: BMC Urol Journal subject: UROLOGIA Year: 2022 Document type: Article Affiliation country: Japón Country of publication: Reino Unido